About this trial
The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with radiological suspected diagnosis of a low grade glioma
Age ≥ 18 years. There is no upper age limit.
Disqualifiers
Severe neurological or psychiatric disorder interfering with ability to give an informed consent
No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.
Trial population
All adult patients with radiological suspected diagnosis of a low grade glioma
Trial design
Cohort
Prospective
Treatments tested in this trial
no interventions
Other intervention
Treatment groups
Trial outcomes
Primary outcomes
Progression-free survival (PFS)
Overall survival (OS)
Secondary outcomes
Extent of tumor resection
calculated based on volumetric assessement of tumor in cm³ and residual tumor in pre and postoperative MRI
Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-30
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Ulm
Lead sponsor
Charite University, Berlin, Germany
Collaborator